Abstract
Cell surface proteins are key regulators of fundamental cellular processes, and therefore often at the root of human diseases. Thus, a large number of targeted drugs which are ap-proved or under development act upon cell surface proteins. While down-regulation of sur-face proteins by many natural ligands is well established, the ability of drug candidates to cause internalization or degradation of the target is only recently moving into focus. This property is important both for the pharmacokinetics and pharmacodynamics of the drug, but may also constitute a potential resistance mechanism. The enormous numbers of drug can-didates targeting cell surface molecules, comprising small molecules, antibodies, or alterna-tive protein scaffolds, necessitate methods for the investigation of internalization and degra-dation in high throughput. Here, we present a generic high-throughput assay protocol, which allows the simultaneous and independent quantification of internalization and degradation of surface proteins on a single-cell level. Since we fuse a HaloTag to the cell surface protein of interest and exploit the differential cell permeability of two fluorescent HaloTag ligands, no labeling of the molecules to be screened is required. In contrast to previously described ap-proaches, our homogenous assay is performed with adherent live cells in a 96-well format. Through channel rescaling, we are furthermore able to obtain true relative abundances of surface and internal protein. We demonstrate the applicability of our procedure to three major drug targets, EGFR, HER2, and EpCAM, examining a selection of well-investigated, but also novel small molecule ligands and protein affinity reagents.
Funding Information
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_166676)

This publication has 55 references indexed in Scilit: